Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial function as intermediary endpoint in hypertension: comments

W Kiowski1

  • 1Division of Cardiology, University Hospital, Zürich, Switzerland.

Blood Pressure. Supplement
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.

Clinical pharmacology and therapeutics·2010
Same author

Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.

Journal of hypertension·2003
Same author

Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.

American heart journal·2003
Same author

[Medicamentous management of acute coronary syndrome without ST segment elevation].

Therapeutische Umschau. Revue therapeutique·2002
Same author

Rationale and perspective of endothelin-1 antagonism in acute heart failure.

Journal of cardiovascular pharmacology·2002
Same author

Clinical picture: Amiodarone-induced pulmonary mass and cutaneous vasculitis.

Lancet (London, England)·2002
Same journal

Efficacy and safety of early versus late titration of fixed-dose irbesartan/hydrochlorothiazide: ACTUAL study.

Blood pressure. Supplement·2012
Same journal

Efficacy and safety of valsartan in hypertensive Taiwanese patients: post-marketing surveillance study.

Blood pressure. Supplement·2012
Same journal

Effect of fixed dose combinations of metoprolol and amlodipine in essential hypertension: MARS--a randomized controlled trial.

Blood pressure. Supplement·2012
Same journal

Post-registration studies for the evaluation of antihypertensive drugs.

Blood pressure. Supplement·2012
Same journal

Effects of candesartan versus amlodipine on home-measured blood pressure, QT dispersion and left ventricular hypertrophy in high-risk hypertensive patients.

Blood pressure. Supplement·2011
Same journal

Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.

Blood pressure. Supplement·2010
See all related articles

Endothelial function is a key marker for hypertension and atherosclerosis. While improving endothelial function may theoretically prevent atherosclerosis, current studies in hypertension reveal unresolved issues regarding its therapeutic application.

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Hypertension Research

Background:

  • The response-to-injury theory posits endothelial dysfunction as an early event in atherosclerosis.
  • Endothelial function is considered a potential surrogate endpoint for hypertension and its treatment.
  • Improving endothelial function is theoretically linked to preventing or slowing atherosclerotic progression.

Purpose of the Study:

  • To evaluate the role of endothelial function as an endpoint in hypertension research.
  • To critically examine the application of endothelial function in antihypertensive therapy.
  • To identify unresolved issues in studies assessing endothelial function in hypertension.

Main Methods:

  • Review of existing literature on endothelial function in hypertension.

Related Experiment Videos

  • Analysis of studies investigating endothelial function as a surrogate endpoint.
  • Scrutiny of clinical trials related to antihypertensive therapy and endothelial function.

    • Main Results:

    • Endothelial dysfunction is recognized as an early indicator in the development of atherosclerosis.
    • Theoretically, enhancing endothelial function could aid in preventing or mitigating atherosclerosis.
    • Significant unresolved questions persist in the practical application of these findings in hypertension studies.

    Conclusions:

    • Endothelial function holds theoretical promise as a surrogate endpoint in hypertension.
    • Further research is needed to address the unresolved issues in utilizing endothelial function in antihypertensive strategies.
    • The clinical utility of targeting endothelial function for atherosclerosis prevention in hypertensive patients requires clarification.